Twin Tree Management, LP Beam Therapeutics Inc. Transaction History
Twin Tree Management, LP
- $51.8 Billion
- Q2 2025
A detailed history of Twin Tree Management, LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Twin Tree Management, LP holds 6,800 shares of BEAM stock, worth $161,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,800Holding current value
$161,840% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BEAM
# of Institutions
247Shares Held
95.6MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$238 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$231 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$211 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$182 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.83MShares$115 Million0.07% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.67B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...